Kathrin Schwarte Selected Research

Kathrin Schwarte Research Topics

6	Major Depressive Disorder (Major Depressive Disorders) 10/2023 - 08/2014
2	Inflammation (Inflammations) 08/2023 - 01/2022
2	Mental Disorders (Mental Disorder) 01/2020 - 12/2014
2	Panic Disorder (Panic Attack) 10/2013 - 10/2012
1	Cognitive Dysfunction 10/2023
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2017
1	Multiple Sclerosis 12/2016
1	Relapsing-Remitting Multiple Sclerosis 12/2016
1	Anxiety Disorders (Anxiety Disorder) 10/2013

4	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 10/2012
2	Celecoxib (Celebrex)FDA Link 10/2023 - 08/2023
2	VortioxetineIBA 10/2023 - 08/2023
2	sodium bisulfite FDA Link 01/2015 - 08/2014
2	Monoamine Oxidase (MAO)IBA 01/2015 - 10/2012
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2013 - 10/2012
1	C-Reactive ProteinIBA 08/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	ElementsIBA 01/2018
1	Chemokine CCL17IBA 11/2017
1	Alemtuzumab (Campath)FDA Link 12/2016
1	Adenosine A1 ReceptorIBA 12/2014
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2014
1	Carboxy-LyasesIBA 10/2013
1	glutamate decarboxylase 1IBA 10/2013
1	gamma-Aminobutyric Acid (GABA)IBA 10/2013
1	Glutamic Acid (Glutamate)FDA Link 10/2013